Nov 26, 2024

Featuring an interview with Dr Seth Wander, including the following topics:

• ASCO Guidelines Rapid Recommendations Update for Testing for ESR1 Mutations (0:00)
• Real-world elacestrant use patterns and genomic biomarkers (4:43)
• Circulating tumor DNA (ctDNA) analyses with imlunestrant in the EMBER Phase I study (8:50)

Nov 26, 2024

Featuring perspectives from Dr Sarah B Goldberg, Dr Brad S Kahl, Dr Sagar Lonial, Dr Joyce O’Shaughnessy, Dr Noopur Raje, Dr Joshua K Sabari, Dr Matthew R Smith, Dr Sonali M Smith, Dr Sandy Srinivas and Dr Seth Wander, including the following topics:

• Introduction (0:00)
• Current Therapeutic Approaches for...

Nov 25, 2024

Featuring perspectives from Dr Suresh S Ramalingam and Dr Gregory J Riely, including the following topics:

• Introduction: Tumor Treating Fields (0:00)
• Nontargeted Therapy for Lung Cancer — Dr Ramalingam (4:02)
• Targeted Therapy for Non-Small Cell Lung Cancer — Dr Riely (33:50)

CME information and select...

Nov 23, 2024

Featuring perspectives from Dr Nicole Lamanna, including the following topics:

• Introduction (0:00)
• Case: A man in his late 60s with IGHV-mutated chronic lymphocytic leukemia (CLL) (trisomy 12) and progressive adenopathy — Bhavana (Tina) Bhatnagar, DO (1:22)
• Case: A woman in her mid 70s with IGHV-unmutated, del(13q)...

Nov 21, 2024

Featuring a slide presentation and related discussion from Dr Emanuela Palmerini, including the following topics:

• Background, diagnosis and disease course of tenosynovial giant cell tumor (TGCT) (0:00)
• Clinical data supporting systemic therapy for TGCT (10:19)
• Clinical data on emerging therapies for TGCT (17:28)